AstraZeneca

CDSCO approves AstraZeneca’s Dapagliflozin with additional indication for treating CKD and heart failure patients

Read more

Sanofi and AstraZeneca win EU approval for prevention of infant RSV

Read more

AstraZeneca drug fails one main goal in study of chronic immune disease

Read more

EU recommends marketing approval for Evusheld to treat COVID-19

Read more

AstraZeneca launches iPHARMACY to upskill pharmacists across India

Read more

AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures

Read more

US plans to move COVID vaccines and treatments to private markets in 2023

Read more

Thai king’s medical firm reports record profit after vaccine deal with AstraZeneca

Read more

DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast cancer

Read more

AstraZeneca completes acquisition of TeneoTwo

Read more